Dr. Bedri Toker, General Manager of OnkoResult in Turkey, pointed out in his speech at the Asian Congress of Clinical Pathology and Laboratory Medicine (ASCPaLM) in March this year (2016) that taking DR-70 blood test as an example, it has high sensitivity and high specificity, and can screen for a variety of epithelial cell cancers, such as: colorectal cancer, lung cancer, breast cancer, stomach cancer, liver cancer, esophageal cancer, pancreatic cancer, etc., this non-invasive diagnostic method, compared with other invasive and expensive diagnoses, The DR-70 has a higher level of convenience.
